High Vista Strategies LLC Sutro Biopharma, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $702,845 - $928,551	-38,982 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $488,400 - $662,915	-24,071 Reduced 38.18%	38,982 $887,000
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $16,652 - $39,303	-1,639 Reduced 2.53%	63,053 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $481,308 - $850,699	64,692 New	64,692 $651,000

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $101M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.